Search by
OpSens Inc., a Quebec-based provider of cardiology-focused medical devices, signed a definitive agreement with global healthcare firm Haemonetics Corporation wherein Haemonetics will acquire OpSens for $345 million. The deal is expected to close by the end of January 2024, subject to customary closing conditions.
Parties
Company
OpSens Inc.
Company
Haemonetics Corporation
Deal Type
Merger & AcquisitionIndustry
HealthcareTransaction
$ 345,000,000Deal Status
ClosedClosing Date
12 December 2023